Mesotherapy With Bicalutamide: A New Treatment for Androgenetic Alopecia
January 2023
in “
International Journal of Trichology
”
Studysummary This study found that bicalutamide mesotherapy resulted in subtle hair density improvements and was well tolerated by premenopausal women with androgenetic alopecia.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer